Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

Abstract

LYMPHOCYTES from normal individuals may have considerable levels of cytotoxic reactivity against tumour cells, mediated by NK (natural killer) cells1. There are many similarities between NK cells and the effector cells (K cells) mediating antibody-dependent cell-mediated cytotoxicity (ADCC) against tumour target cells2,3, and they may in fact be identical cells. In vivo inoculation of rodents with viruses4,5, immunostimulants4,6–8, tumour cells4 and other interferon inducers8 results in augmented NK activity. Interferon (IF) was shown to have a major role in rapidly boosting mouse NK activity, both in vivo9,10 and in vitro9. Trinchieri and Santoli11 have suggested that IF could also augment human NK activity. However, the preparations used might have contained a variety of other lymphokines. The present study shows that IF can indeed augment human NK activity and also ADCC.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Herberman, R. B. & Holden, H. T. Adv. Cancer Res. 27, 305–377 (1978).

    Article  CAS  Google Scholar 

  2. Kay, H. D., Bonnard, G. D., West, W. H. & Herberman, R. B. J. Immun. 118, 2058–2066 (1977).

    CAS  PubMed  Google Scholar 

  3. Santoni, A., Herberman, R. B. & Holden, H. T. J. natn. Cancer Inst. (in the press).

  4. Herberman, R. B., Nunn, M. E., Holden, H. T., Staal, S. & Djeu, J. Y. Int. J. Cancer 19, 555–564 (1977).

    Article  CAS  Google Scholar 

  5. Welsh, R. M., Jr & Zinkernagel, R. M. Nature 268, 646–648 (1977).

    Article  ADS  Google Scholar 

  6. Wolfe, S. A., Tracey, D. E. & Henney, C. S. Nature 262, 584–586 (1976).

    Article  ADS  CAS  Google Scholar 

  7. Wolfe, S. A., Tracey, D. E. & Henney, C. S. J. Immun. 119, 1152–1158 (1977).

    CAS  PubMed  Google Scholar 

  8. Oehler, J. R., Lindsay, L. R., Nunn, M. E., Holden, H. T. & Herberman, R. B. Int. J. Cancer 21, 210–220 (1978).

    Article  CAS  Google Scholar 

  9. Djeu, J. Y., Heinbaugh, J. A., Holden, H. T. & Herberman, R. B. J. Immun. (in the press).

  10. Gidlund, M. Örn, A., Wigzell, H., Senik, A. & Gresser, I. Nature 273, 759–761 (1978).

    Article  ADS  CAS  Google Scholar 

  11. Trinchieri, G. & Santoli, D. J. exp. Med. 147, 1314–1321 (1978).

    Article  CAS  Google Scholar 

  12. Cantell, K., Hrovonen, S., Mogensen, K. E. & Pyhälä, L. In Vitro Monogr. 3, 35–38 (1973).

    Google Scholar 

  13. Berg, K., Ogburn, C. A., Paucker, K., Mogensen, K. E. & Cantell, K. J. Immun. 114, 640–644 (1975).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

HERBERMAN, R., ORTALDO, J. & BONNARD, G. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 277, 221–223 (1979). https://doi.org/10.1038/277221a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/277221a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing